Krieger Scientific's Joseph Morwald on why over-reliance on AI and under-reliance on human expertise is driving the surge in FDA warning letters.
Joseph Morwald
Advertisement
Joseph Morwald is founder and CEO of Krieger Scientific.
Articles by Joseph Morwald
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition
2
Senior Source Denies AstraZeneca and Bristol Myers Deal Talks : Report
3
Pharmaceutical Executive Daily: Source Denies AstraZeneca-Bristol Myers Merger Talks
4
Mergers as Strategic Architecture: Rethinking How to Evaluate the AstraZeneca–BMS Rumors
5